Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications.
暂无分享,去创建一个
Zhongxing Liao | R. Komaki | Z. Liao | B. Stea | A. Chi | N. Nguyen | Jiahong Xu | Ritsuko Komaki | Alexander Chi | Nam P Nguyen | Jiahong Xu | Baldassarre Stea | Jiahong Xu
[1] Shinichi Shimizu,et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. , 2003, International journal of radiation oncology, biology, physics.
[2] G. Sibley. Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma , 1998, Cancer.
[3] I. Lax,et al. Radiosurgery for Tumors in the Body: Clinical Experience Using a New Method , 1998 .
[4] J F Fowler,et al. A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy. , 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).
[5] Matthias Guckenberger,et al. Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation. , 2009, International journal of radiation oncology, biology, physics.
[6] J. Chang,et al. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers. , 2008, International journal of radiation oncology, biology, physics.
[7] B. Jeremic,et al. Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer. , 2002, International journal of radiation oncology, biology, physics.
[8] I. Sarikaya,et al. Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer , 2009, Journal of hematology & oncology.
[9] Lech Papiez,et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. , 2009, International journal of radiation oncology, biology, physics.
[10] David J Sugarbaker,et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] R. Tsuchiya,et al. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. , 2001, The Annals of thoracic surgery.
[12] Michael Flentje,et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. , 2004, International journal of radiation oncology, biology, physics.
[13] Robert D Timmerman,et al. Stereotactic body radiation therapy. , 2004, Current problems in cancer.
[14] M. Schell,et al. Central thoracic lesions treated with hypofractionated stereotactic body radiotherapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] Masahiro Hiraoka,et al. Current status of stereotactic body radiotherapy for lung cancer , 2007, International Journal of Clinical Oncology.
[16] Lu Wang,et al. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] Yongshun Chen,et al. Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: long-term results and efficacy of adjuvant chemotherapy. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] D. Heron,et al. Stereotactic radiosurgery for the treatment of stage I non-small cell lung cancer in high-risk patients. , 2009, The Journal of thoracic and cardiovascular surgery.
[19] M E Burt,et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. , 1995, The Journal of thoracic and cardiovascular surgery.
[20] Jeffrey D Bradley,et al. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma. , 2002, International journal of radiation oncology, biology, physics.
[21] I. Lax,et al. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. , 1994, Acta oncologica.
[22] Hiroki Shirato,et al. STEREOTACTIC RADIATION THERAPY WORKSHOP Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study , 2007 .
[23] L. Gaspar,et al. Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. , 2009, International journal of radiation oncology, biology, physics.
[24] D. N. Watkins,et al. Cancer stem cells and the ontogeny of lung cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] Seong Soo Shin,et al. Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. , 2009, Lung cancer.
[26] I. Lax,et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. , 1995, Acta oncologica.
[27] Jan Nyman,et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries , 2006, Acta oncologica.
[28] R. Rami-Porta,et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[29] J. Wong,et al. Long-term Results of Computed Tomography Guided Hypofractionated Stereotactic Radiotherapy for Stage I Non-small Cell Lung Cancers , 2008 .
[30] Y. Onodera,et al. Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. , 2008, International journal of radiation oncology, biology, physics.
[31] Jacques Bernier,et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. , 1997, Radiotherapy and Oncology.
[32] John D Fenwick,et al. A challenge to traditional radiation oncology. , 2004, International journal of radiation oncology, biology, physics.
[33] R. T. Ten Haken,et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. , 2005, International journal of radiation oncology, biology, physics.
[34] B. Salter,et al. Stereotactic body radiation therapy for centrally located lung lesions , 2006, Acta oncologica.
[35] Masahiro Hiraoka,et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. , 2005, International journal of radiation oncology, biology, physics.
[36] Quynh-Thu Le,et al. Results of a Phase I Dose-Escalation Study Using Single-Fraction Stereotactic Radiotherapy for Lung Tumors , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[37] Hiroshi Onishi,et al. Clinical outcomes of stereotactic radiotherapy for stage I non-small cell lung cancer using a novel irradiation technique: patient self-controlled breath-hold and beam switching using a combination of linear accelerator and CT scanner. , 2004, Lung cancer.
[38] M. Nishimura,et al. Small‐volume image‐guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable Stage I nonsmall cell lung carcinomas , 2002, Cancer.
[39] Russ Hamilton,et al. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma. , 2008, Cancer treatment reviews.
[40] Joe Y. Chang,et al. Stereotactic body radiation therapy for stage I non-small cell lung cancer. , 2007, Thoracic surgery clinics.
[41] Ping Li,et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.
[42] K. Johansson,et al. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer--mature results for medically inoperable patients. , 2006, Lung cancer.
[43] D. Ball. Stereotactic radiotherapy for nonsmall cell lung cancer , 2008, Current opinion in pulmonary medicine.
[44] Toshio Ohashi,et al. Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm. , 2009, International journal of radiation oncology, biology, physics.
[45] Jay S. Cooper,et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003 , 1999 .
[46] Kurt Baier,et al. Dose-response in stereotactic irradiation of lung tumors. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[47] L V Rubinstein,et al. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. , 1995, The Annals of thoracic surgery.
[48] Lech Papiez,et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. , 2005, International journal of radiation oncology, biology, physics.
[49] C. Ling,et al. Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma , 2005, Cancer.
[50] Yoshihiro Takai,et al. A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[51] Jan Nyman,et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[52] E. Smit,et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.
[53] K. Trott,et al. Cancer stem cells and radiotherapy , 2009, International journal of radiation biology.
[54] C. Mountain,et al. The international system for staging lung cancer. , 2000, Seminars in surgical oncology.
[55] P. Pairolero,et al. Bronchoalveolar carcinoma: factors affecting survival. , 1991, The Annals of thoracic surgery.
[56] Angelika Hoess,et al. Stereotactic single‐dose radiotherapy (radiosurgery) of early stage nonsmall‐cell lung cancer (NSCLC) , 2007, Cancer.
[57] Joe Y. Chang,et al. Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer. , 2008, International journal of radiation oncology, biology, physics.
[58] R. V. van Klaveren,et al. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[59] Shinichi Shimizu,et al. Clinical outcomes of stereotactic body radiotherapy for small lung lesions clinically diagnosed as primary lung cancer on radiologic examination. , 2009, International journal of radiation oncology, biology, physics.
[60] Luca Errico,et al. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[61] S. Tung,et al. Hypofractionated stereotactic radiotherapy for medically inoperable stage I non-small cell lung cancer--report on clinical outcome and dose to critical organs. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[62] R. Timmerman,et al. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer , 2008, Expert review of anticancer therapy.
[63] R. Rami-Porta,et al. European trends in preoperative and intraoperative nodal staging: ESTS guidelines. , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[64] R K Ten Haken,et al. Estimation of tumor control probability model parameters from 3-D dose distributions of non-small cell lung cancer patients. , 1999, Lung cancer.
[65] M. Parmar,et al. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial , 1997, The Lancet.
[66] Stephen Lam,et al. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. , 2007, Cancer research.
[67] A. Ragaz,et al. [Inoperable non-small-cell bronchial carcinoma: macroscopic and microscopic tumor behavior during and after radiotherapy with curative intent]. , 1999, Praxis.
[68] Matthias Guckenberger,et al. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[69] J. Petersen,et al. Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer , 2005 .
[70] I. Lax,et al. The role of radiotherapy in treatment of stage I non-small cell lung cancer. , 2003, Lung cancer.
[71] Jinming Yu,et al. A Randomized Study of Involved-Field Irradiation Versus Elective Nodal Irradiation in Combination With Concurrent Chemotherapy for Inoperable Stage III Nonsmall Cell Lung Cancer , 2007, American journal of clinical oncology.
[72] Joachim Widder,et al. Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study , 2009, Radiation oncology.
[73] Jan-Jakob Sonke,et al. Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[74] H. Geinitz,et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC) , 2006, Acta oncologica.
[75] Robert D Timmerman,et al. The North American Experience with Stereotactic Body Radiation Therapy in Non-small Cell Lung Cancer , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[76] K. Esato,et al. Systematic Lymph Node Dissection for Clinically Diagnosed Peripheral Non-Small-Cell Lung Cancer Less Than 2 cm in Diameter , 1998, World Journal of Surgery.
[77] Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors , 2006, Acta oncologica.
[78] Lech Papiez,et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[79] W. Mühlnickel,et al. Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning. , 2008, Lung cancer.
[80] R K Ten Haken,et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[81] D. Hayes,et al. Late Complications of High-Dose (≥66 Gy) Thoracic Conformal Radiation Therapy in Combined Modality Trials in Unresectable Stage III Non-small Cell Lung Cancer , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[82] R. Timmerman,et al. Stereotactic body radiation therapy for early stage non-small cell lung cancer (Expert Review of Anticancer Therapy (2008) 8, 1 (87-98)) , 2009 .
[83] C. Perez,et al. Principles and Practice of Radiation Oncology , 1987 .
[84] Kurt Baier,et al. Dose, volume, and tumor control prediction in primary radiotherapy of non-small-cell lung cancer. , 2002, International journal of radiation oncology, biology, physics.
[85] T. Hashimoto,et al. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. , 2007, International journal of radiation oncology, biology, physics.
[86] J. Fowler,et al. On cold spots in tumor subvolumes. , 2002, Medical physics.
[87] Jeffrey Bradley,et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. , 2005, International journal of radiation oncology, biology, physics.